Cortechs Labs, Inc.
San Diego, CA · CIK 0001582829 · Medtech · Private
Deep learning software (RSI-AI and RSI-AI+) that analyzes advanced MRI data to predict prostate cancer location and grade, integrated with clinical risk assessment on a cloud platform
cortechslabs.com →- Grants
- $6.8M
- 13 awards
- Sector median: 1
- Raised
- $9.1M
- 3 Form D · May 2020
- 77 months since last filing
- Contracts
- $12K
- 2 awards · Veterans Affairs
- #625 of 4531 in medtech
- Patents
- 5
- 3 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Written Report On Analyses On Brain Images. | $5,000 | |
| Federal contract | Department of Veterans Affairs · Services To Perform Volumetric Analyses On The Fmri Brain Images. | $7,000 | |
| Private capital raised | Form D · SEC | $1,974,302 | |
| Private capital raised | Form D · SEC | $1,213,600 | |
| Federal grant | Department of Health and Human Services · Phase II · Diagnosis of Alzheimer's Disease and Prediction of Clinical Progression Using an Automated PET Image Analysis Tool | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Diagnosis of Alzheimer's Disease and Prediction of Clinical Progression Using an Automated PET Image Analysis Tool | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Diagnosis of Alzheimer's Disease and Prediction of Clinical Progression Using an Automated PET Image Analysis Tool | $500,000 | |
| Private capital raised | Form D · SEC | $5,883,723 | |
| Federal grant | Department of Health and Human Services · Phase II · RSI-AI: Predicting clinically significant prostate cancer to guide biopsy decisions by combining advanced tissue microstructure imaging with deep learning | $251,720 | |
| Federal grant | Department of Health and Human Services · Phase I · Towards a Virtual Biopsy: An improved multimodal imaging biomarker to guide treatment decisions in neuro-oncology by combining advanced tissue microstructure imaging with deep learning | $254,685 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantifying microstructural changes in Alzheimer's disease using Restriction Spectrum Imaging | $247,965 | |
| Federal grant | Department of Health and Human Services · Phase II · RSI-AI: Predicting clinically significant prostate cancer to guide biopsy decisions by combining advanced tissue microstructure imaging with deep learning | $735,773 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantifying microstructural changes in Alzheimer's disease using Restriction Spectrum Imaging | $550,576 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantifying microstructural changes in Alzheimer's disease using Restriction Spectrum Imaging | $550,576 | |
| Federal grant | Department of Health and Human Services · Phase II · RSI-AI: Predicting clinically significant prostate cancer to guide biopsy decisions by combining advanced tissue microstructure imaging with deep learning | $860,506 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantification of ARIA During the Treatment of Alzheimer's Patients | $295,759 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantification of ARIA During the Treatment of Alzheimer's Patients | $932,694 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantification of ARIA During the Treatment of Alzheimer's Patients | $932,694 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 622 | EnteroTrack, LLC | $13K | $4.9M |
| 623 | MERCATOR MEDSYSTEMS, INC. | $13K | $17M |
| 624 | VULINTUS, INC | $12K | — |
| 625 | Cortechs Labs, Inc. | $12K | $9.1M |
| 626 | MIYAZAKI ENTERPRISES LLC | $11K | — |
| 627 | PROPRIA LLC | $11K | $574K |
| 628 | DuraStat LLC | $11K | $6.8M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Chris AirriessDirector · Executive Officer
- Thomas BarichExecutive Officer
- James BrewerDirector
- Anders DaleDirector
- Gerald GibsonDirector
- Jerry GibsonDirector
- Eric HalgrenDirector
- Paul MirabellaDirector
- Michael SmithDirector · Executive Officer
- Guri StarkDirector · Executive Officer
- Kong TanDirector
- Nathan WhiteDirector · Executive Officer
Patents
- Covariate Modulate Atlasgranted
- System And Method For Integrating Genotypic Information And Phenotypic Measurements For Precision Health Assessmentsapplication
- Covariate Modulate Atlasgranted
- Covariate Modulate Atlasgranted
- Covariate Modulate Atlasapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.